These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

40 related articles for article (PubMed ID: 36327134)

  • 1. Estimate the prevalence of daily caffeine consumption, caffeine use disorder, caffeine withdrawal and perceived harm in Iran: a cross-sectional study.
    Abdoli F; Davoudi M; Momeni F; Djafari F; Dolatshahi B; Hosseinzadeh S; Aliyaki H; Khalili Z
    Sci Rep; 2024 Apr; 14(1):7644. PubMed ID: 38561480
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cannabis Use Disorder Among First-Year Undergraduate Students in Gaborone, Botswana.
    Olashore AA; Opondo PR; Ogunjumo JA; Ayugi JO
    Subst Abuse; 2020; 14():1178221820904136. PubMed ID: 32214818
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Opioid Use Disorder: A Qualitative Exploratory Analysis of Potential Misunderstandings in Patients with Chronic Non-Cancer Pain.
    Kufeld N; Weckbecker K; Michalak J; Häuser W; Petzke F; Scherbaum N; Specka M; Schmidt A; Piotrowski A; Kersting C; Just JM
    J Pain Res; 2024; 17():873-885. PubMed ID: 38476877
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High-Cost and High-Dose Prescriptions of Cannabis-Based Medicines.
    Hennig B; Schmidt-Wolf G; Cristinziani A; Cremer-Schaeffer P; Marschall U; Petzke F; Häuser W
    Dtsch Arztebl Int; 2023 Nov; 120(47):813-814. PubMed ID: 38154052
    [No Abstract]   [Full Text] [Related]  

  • 5. Drug Interactions of Tetrahydrocannabinol and Cannabidiol in Cannabinoid Drugs.
    Herdegen T; Cascorbi I
    Dtsch Arztebl Int; 2023 Dec; 120(49):833-840. PubMed ID: 37874128
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Individualized and pragmatic: perioperative use of cannabis].
    Tafelski S
    Anaesthesiologie; 2023 Sep; 72(9):619-620. PubMed ID: 37581641
    [No Abstract]   [Full Text] [Related]  

  • 7. Prescriptions of Cannabinoid Drugs, 2019-2022.
    Cremer-Schaeffer P; Hennig B; Schmidt-Wolf G; Marschall U; Petzke F; Häuser W
    Dtsch Arztebl Int; 2023 Mar; 120(11):186-187. PubMed ID: 37222029
    [No Abstract]   [Full Text] [Related]  

  • 8. [Benefits and harms of cannabis-based medicines from the viewpoint of patients with chronic pain and their physicians : A cohort study in three pain centers of the German federal state Saarland].
    Böttge-Wolpers C; Bialas P; Gottschling S; Juckenhöfel S; Konietzke D; Madlinger A; Welsch P; Häuser W
    Schmerz; 2024 Aug; 38(4):241-249. PubMed ID: 36662296
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dimensionality and differential functioning of DSM-5 cannabis use disorder criteria in an online sample of adults with frequent cannabis use.
    Shmulewitz D; Budney AJ; Borodovsky JT; Bujno JM; Walsh CA; Struble CA; Livne O; Habib MI; Aharonovich E; Hasin DS
    J Psychiatr Res; 2023 Jul; 163():211-221. PubMed ID: 37224773
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cannabis-based medicines for chronic neuropathic pain in adults.
    Mücke M; Phillips T; Radbruch L; Petzke F; Häuser W
    Cochrane Database Syst Rev; 2018 Mar; 3(3):CD012182. PubMed ID: 29513392
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cannabis Use and its Association with Psychological Disorders.
    Urits I; Gress K; Charipova K; Li N; Berger AA; Cornett EM; Hasoon J; Kassem H; Kaye AD; Viswanath O
    Psychopharmacol Bull; 2020 May; 50(2):56-67. PubMed ID: 32508368
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cannabis use disorder in patients with chronic pain: overestimation and underestimation in a cross-sectional observational study in 3 German pain management centres.
    Bialas P; Böttge-Wolpers C; Fitzcharles MA; Gottschling S; Konietzke D; Juckenhöfel S; Madlinger A; Welsch P; Häuser W
    Pain; 2023 Jun; 164(6):1303-1311. PubMed ID: 36327134
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence and correlates of cannabis use disorder among Australians using cannabis products to treat a medical condition.
    Mills L; Lintzeris N; O'Malley M; Arnold JC; McGregor IS
    Drug Alcohol Rev; 2022 Jul; 41(5):1095-1108. PubMed ID: 35172040
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Problematic Use of Prescription Opioids and Medicinal Cannabis Among Patients Suffering from Chronic Pain.
    Feingold D; Goor-Aryeh I; Bril S; Delayahu Y; Lev-Ran S
    Pain Med; 2017 Feb; 18(2):294-306. PubMed ID: 28204792
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.